Kopeček J - Search Results

1

Design of smart HPMA copolymer-based nanomedicines.

Yang J, Kopeček J. Yang J, et al. Among authors: kopecek j. J Control Release. 2016 Oct 28;240:9-23. doi: 10.1016/j.jconrel.2015.10.003. Epub 2015 Oct 3. J Control Release. 2016. PMID: 26437260 Free PMC article. Review.

2

HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro.

Omelyanenko V, Kopecková P, Gentry C, Shiah JG, Kopecek J. Omelyanenko V, et al. Among authors: kopecek j. J Drug Target. 1996;3(5):357-73. doi: 10.3109/10611869608996827. J Drug Target. 1996. PMID: 8866655

3

HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.

Omelyanenko V, Gentry C, Kopecková P, Kopecek J. Omelyanenko V, et al. Among authors: kopecek j. Int J Cancer. 1998 Feb 9;75(4):600-8. doi: 10.1002/(sici)1097-0215(19980209)75:4<600::aid-ijc18>3.0.co;2-c. Int J Cancer. 1998. PMID: 9466663 Free article.

4

HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line.

Minko T, Kopecková P, Pozharov V, Kopecek J. Minko T, et al. Among authors: kopecek j. J Control Release. 1998 Jul 31;54(2):223-33. doi: 10.1016/s0168-3659(98)00009-1. J Control Release. 1998. PMID: 9724909

5

Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.

Omelyanenko V, Kopecková P, Gentry C, Kopecek J. Omelyanenko V, et al. Among authors: kopecek j. J Control Release. 1998 Apr 30;53(1-3):25-37. doi: 10.1016/s0168-3659(97)00235-6. J Control Release. 1998. PMID: 9741911

6

Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line.

Minko T, Kopecková P, Kopecek J. Minko T, et al. Among authors: kopecek j. J Control Release. 1999 May 20;59(2):133-48. doi: 10.1016/s0168-3659(98)00186-2. J Control Release. 1999. PMID: 10332049

7

High-molecular weight HPMA copolymer-adriamycin conjugates.

Dvorák M, Kopecková P, Kopecek J. Dvorák M, et al. Among authors: kopecek j. J Control Release. 1999 Aug 5;60(2-3):321-32. doi: 10.1016/s0168-3659(99)00087-5. J Control Release. 1999. PMID: 10425337

8

Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.

Minko T, Kopecková P, Kopecek J. Minko T, et al. Among authors: kopecek j. Pharm Res. 1999 Jul;16(7):986-96. doi: 10.1023/a:1018959029186. Pharm Res. 1999. PMID: 10450921

9

Biorecognition of HPMA copolymer-adriamycin conjugates by lymphocytes mediated by synthetic receptor binding epitopes.

Omelyanenko V, Kopecková P, Prakash RK, Ebert CD, Kopecek J. Omelyanenko V, et al. Among authors: kopecek j. Pharm Res. 1999 Jul;16(7):1010-9. doi: 10.1023/a:1018975414165. Pharm Res. 1999. PMID: 10450924

10

Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.

Shiah JJ, Sun Y, Peterson CM, Kopecek J. Shiah JJ, et al. Among authors: kopecek j. J Control Release. 1999 Aug 27;61(1-2):145-57. doi: 10.1016/s0168-3659(99)00113-3. J Control Release. 1999. PMID: 10469911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

318 results

Search Page